These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24952721)
1. RNAi-Based Therapy: Combating Shrimp Viral Diseases. Alam MS; Islam MN; Das M; Islam SF; Rabbane MG; Karim E; Roy A; Alam MS; Ahmed R; Kibria ASM Viruses; 2023 Oct; 15(10):. PubMed ID: 37896827 [TBL] [Abstract][Full Text] [Related]
2. Cancer biology functional genomics: From small RNAs to big dreams. Sundara Rajan S; Ludwig KR; Hall KL; Jones TL; Caplen NJ Mol Carcinog; 2020 Dec; 59(12):1343-1361. PubMed ID: 33043516 [TBL] [Abstract][Full Text] [Related]
3. RNA ac Tao L; Lu Y; Chen Z; Ge L; He J; Peng J; Wang H Sci China Life Sci; 2024 Apr; 67(4):832-835. PubMed ID: 38324129 [No Abstract] [Full Text] [Related]
4. DISE, an ancient anti-cancer mechanism that senses mutational load in cancerous cells? Patel M; Peter ME Oncotarget; 2023 Sep; 14():839-841. PubMed ID: 37747368 [No Abstract] [Full Text] [Related]
5. Plasmid-driven RNA interference in fish cell lines. Collet B; Collins C; Cheyne V; Lester K In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):189-193. PubMed ID: 35275331 [No Abstract] [Full Text] [Related]
6. Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells. Tzeng YT; Liu PF; Li JY; Liu LF; Kuo SY; Hsieh CW; Lee CH; Wu CH; Hsiao M; Chang HT; Shu CW Front Pharmacol; 2018; 9():1285. PubMed ID: 30473665 [No Abstract] [Full Text] [Related]
7. Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy. Allan KJ; Mahoney DJ; Baird SD; Lefebvre CA; Stojdl DF J Vis Exp; 2018 Apr; (134):. PubMed ID: 29683442 [TBL] [Abstract][Full Text] [Related]
8. Approaches to modernize the combination drug development paradigm. Day D; Siu LL Genome Med; 2016 Oct; 8(1):115. PubMed ID: 27793177 [TBL] [Abstract][Full Text] [Related]
9. A genome-wide loss-of-function screening method for minimizing false-negatives caused by functional redundancy. Mao L; Liu C; Wang Z; Niu X; Xue L; Zhou Z; Cai Z; Yu M; Li Y; Wu D; Li L Cell Res; 2016 Sep; 26(9):1067-70. PubMed ID: 27561817 [No Abstract] [Full Text] [Related]
10. Hybridisation potential of 1',3'-Di-O-methylaltropyranoside nucleic acids. Venkatesham A; Kachare D; Schepers G; Rozenski J; Froeyen M; Van Aerschot A Molecules; 2015 Mar; 20(3):4020-41. PubMed ID: 25741897 [TBL] [Abstract][Full Text] [Related]
11. [RNA interference: biology and perspectives of application in biomedicine and biotechnology]. Vil'gel'm AE; Chumakov SP; Prasolov VS Mol Biol (Mosk); 2006; 40(3):387-403. PubMed ID: 16813159 [TBL] [Abstract][Full Text] [Related]
12. RNA interference technology used for the study of aquatic virus infections. Reshi ML; Wu JL; Wang HV; Hong JR Fish Shellfish Immunol; 2014 Sep; 40(1):14-23. PubMed ID: 24945574 [TBL] [Abstract][Full Text] [Related]
13. Leveraging therapeutic potential of multi-targeted siRNA inhibitors. Ge Q; Xu JJ; Evans DM; Mixson AJ; Yang HY; Lu PY Future Med Chem; 2009 Dec; 1(9):1671-81. PubMed ID: 21425985 [TBL] [Abstract][Full Text] [Related]
14. Applications of RNA interference high-throughput screening technology in cancer biology and virology. Gao S; Yang C; Jiang S; Xu XN; Lu X; He YW; Cheung A; Wang H Protein Cell; 2014 Nov; 5(11):805-15. PubMed ID: 24952721 [TBL] [Abstract][Full Text] [Related]
15. RNAi and miRNA in viral infections and cancers. Mollaie HR; Monavari SH; Arabzadeh SA; Shamsi-Shahrabadi M; Fazlalipour M; Afshar RM Asian Pac J Cancer Prev; 2013; 14(12):7045-56. PubMed ID: 24460249 [TBL] [Abstract][Full Text] [Related]
16. Strategies for silencing human disease using RNA interference. Kim DH; Rossi JJ Nat Rev Genet; 2007 Mar; 8(3):173-84. PubMed ID: 17304245 [TBL] [Abstract][Full Text] [Related]